Datopotamab deruxtecan (Dato-DXd) in locally advanced/metastatic urothelial cancer: Updated results from the phase 1 TROPIONPanTumor01 study.Funda Meric‐Bernstam, Takahiro Kojima, Aaron Lisberg et al.|Journal of Clinical Oncology|2025Cited by 15